Park Place Capital Corp Catalent, Inc. Transaction History

Park Place Capital Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 02, 2024	SELL	$53.58 - $57.02 $4,393 - $4,675	-82 Reduced 84.54%	15 $0
Q1 2024 Apr 18, 2024	SELL	$42.56 - $59.82 $53,497 - $75,193	-1,257 Reduced 92.84%	97 $5,000
Q4 2023 Jan 24, 2024	SELL	$32.18 - $46.57 $5,760 - $8,336	-179 Reduced 11.68%	1,354 $60,000
Q3 2023 Oct 17, 2023	BUY	$44.2 - $50.2 $13,657 - $15,511	309 Added 25.25%	1,533 $69,000
Q2 2023 Aug 04, 2023	SELL	$31.86 - $67.26 $2,230 - $4,708	-70 Reduced 5.41%	1,224 $53,000
Q1 2023 May 02, 2023	BUY	$45.44 - $74.26 $17,948 - $29,332	395 Added 43.94%	1,294 $85,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $37,209 - $72,819	899 New	899 $40,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Park Place Capital Corp with notifications on news.